# IDYA (IDEAYA Biosciences, Inc.) - SEC EDGAR Financial Statements

> IDEAYA Biosciences, Inc. reported $218.7M in revenue and a net loss of $420.0M for the fiscal year ended December 31, 2025 (up 3024.4% year over year), with a -211.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/IDYA
- Markdown: https://convexityos.com/fundamentals/IDYA.md
- SEC CIK: 0001676725
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:20 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001676725&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $218.7M | +3024.4% YoY |
| Operating Income | FY 2025 | -$463.0M | -211.7% margin |
| Net Income | FY 2025 | -$420.0M | -192.0% net margin |
| Diluted EPS | FY 2025 | -$4.08 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$349.8M | -159.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $838.5M | Total debt: $29.70M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $218.7M | $7.00M | $23.39M | $50.93M | $27.94M | $19.54M | $0 | -- | -- |
| Research & Development | $314.7M | $294.7M | $129.5M | $89.54M | $58.16M | $39.70M | $34.32M | $31.75M | $12.38M |
| Total Operating Expenses | $378.0M | $334.0M | $157.8M | $113.4M | $78.21M | $54.88M | $44.27M | $36.42M | $14.44M |
| **Operating Income** | -$159.3M | -$327.0M | -$134.4M | -$62.50M | -$50.27M | -$35.34M | -$44.27M | -$36.42M | -$14.44M |
| **EBITDA** | -$156.6M | -$324.6M | -$132.0M | -$60.40M | -$48.54M | -$33.96M | -$43.03M | -$35.53M | -$14.05M |
| Interest Income | -- | -- | -- | -- | -- | -- | $2.29M | $1.99M | $150K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$113.7M | -$274.5M | -$113.0M | -$58.66M | -$49.76M | -$34.49M | -$41.98M | -$34.35M | -$11.86M |
| Basic EPS | -$1.28 | -$3.36 | -$1.96 | -$1.42 | -$1.41 | -$1.40 | -$3.36 | -$35.92 | -$17.06 |
| **Diluted EPS** | -$1.28 | -$3.36 | -$1.96 | -$1.42 | -$1.41 | -$1.40 | -$3.36 | -$35.92 | -$17.06 |
| Basic Shares Outstanding | 88.5M | 81.7M | 57.5M | 41.4M | 35.3M | 24.7M | 12.5M | 956.3K | 695.4K |
| Diluted Shares Outstanding | 88.5M | 81.7M | 57.5M | 41.4M | 35.3M | 24.7M | 12.5M | 956.3K | 695.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.24M | $8.86M | $6.56M | -- | $207.8M | -- | -- | $7.00M |
| Research & Development | $121.6M | $82.99M | $95.73M | $86.60M | $82.99M | $74.23M | $70.89M | $140.2M |
| Total Operating Expenses | $147.9M | $131.1M | $115.1M | $105.4M | $99.38M | $88.81M | $84.39M | $151.1M |
| **Operating Income** | -$137.6M | -$122.3M | -$108.5M | -$94.57M | $108.5M | -$88.81M | -$84.39M | -$144.1M |
| **EBITDA** | -$137.0M | -$121.6M | -$107.9M | -$93.85M | $109.1M | -$88.09M | -$83.79M | -$143.6M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$125.7M | -$112.5M | -$98.54M | -$83.27M | $119.2M | -$77.49M | -$72.18M | -$130.3M |
| Basic EPS | -$1.22 | -$1.22 | -$1.11 | -- | $1.35 | -$0.88 | -$0.82 | -- |
| **Diluted EPS** | -$1.22 | -$1.22 | -$1.11 | -- | $1.33 | -$0.88 | -$0.82 | -- |
| Basic Shares Outstanding | 102.9M | 92.1M | 88.7M | -- | 88.5M | 88.5M | 88.4M | -- |
| Diluted Shares Outstanding | 102.9M | 92.1M | 88.7M | -- | 89.7M | 88.5M | 88.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $112.8M | $84.38M | $157.0M | $68.63M | $92.05M | $72.04M | $34.07M | $20.50M |
| Short-Term Investments | $526.6M | $591.9M | $368.1M | $296.2M | $154.7M | $211.5M | $64.89M | $69.46M |
| **Cash & Short-Term Investments** | $639.4M | $676.3M | $525.1M | $364.8M | $246.8M | $283.6M | $98.96M | $89.96M |
| Accounts Receivable, Net | -- | $3.0K | $18K | $211K | $1.10M | $1.88M | -- | -- |
| **Total Current Assets** | $666.7M | $689.7M | $532.6M | $370.5M | $251.0M | $288.6M | $101.7M | $90.67M |
| Property, Plant & Equipment, Net | $8.22M | $8.97M | $6.16M | $6.51M | $4.76M | $4.27M | $4.64M | $5.15M |
| Long-Term Investments | $410.3M | $405.8M | $107.5M | $8.32M | $121.3M | $0 | $1.53M | -- |
| Other Non-Current Assets | $126K | -- | $25K | $99K | $291K | $82K | $16K | $46K |
| **Total Non-Current Assets** | $442.6M | $434.4M | $116.7M | $17.52M | $130.4M | $9.66M | $11.35M | $5.87M |
| **Total Assets** | $1.11B | $1.12B | $649.3M | $388.0M | $381.3M | $298.3M | $113.0M | $96.54M |
| Accounts Payable | $17.58M | $15.42M | $6.60M | $4.28M | $2.10M | $953K | $709K | $1.42M |
| Deferred Revenue (Current) | -- | -- | -- | $8.57M | $29.04M | $27.61M | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | $18K | $63K | $114K |
| **Total Current Liabilities** | $58.81M | $46.07M | $27.10M | $31.72M | $45.16M | $38.64M | $6.94M | $5.41M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $5.18M | $31.19M | $56.16M | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $12K | $34K | $113K |
| **Total Non-Current Liabilities** | $27.57M | $18.87M | $1.12M | $6.80M | $34.67M | $61.35M | $5.66M | $1.69M |
| **Total Liabilities** | $86.39M | $64.94M | $28.23M | $38.51M | $79.83M | $100.00M | $12.60M | $7.10M |
| **Total Debt (incl. Leases)** | $27.91M | $19.17M | $2.87M | $3.48M | $5.18M | $6.72M | $6.77M | -- |
| Common Stock | $9.0K | $9.0K | $7.0K | $5.0K | $4.0K | $3.0K | $2.0K | -- |
| Retained Earnings | -$736.5M | -$622.8M | -$348.4M | -$235.4M | -$176.7M | -$127.0M | -$92.49M | -$50.52M |
| Accumulated Other Comp. Income | $2.27M | $812K | $562K | -$2.87M | -$712K | $7.0K | $65K | -$31K |
| **Total Stockholders' Equity** | $1.02B | $1.06B | $621.1M | $349.5M | $301.5M | $198.3M | $100.4M | -$48.95M |
| Total Equity | $1.02B | $1.06B | $621.1M | $349.5M | $301.5M | $198.3M | $100.4M | -$48.95M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $261.5M | $272.6M | $157.5M | $112.8M | $298.9M | $114.6M | $130.0M | $84.38M |
| Short-Term Investments | $577.1M | $556.4M | $513.7M | $526.6M | $488.0M | $555.1M | $562.5M | $591.9M |
| **Cash & Short-Term Investments** | $838.5M | $829.0M | $671.2M | $639.4M | $786.9M | $669.7M | $692.5M | $676.3M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| **Total Current Assets** | $872.0M | $864.0M | $696.1M | $666.7M | $802.7M | $685.6M | $707.9M | $689.7M |
| Property, Plant & Equipment, Net | $7.94M | $8.28M | $8.63M | $8.22M | $8.17M | $8.82M | $8.87M | $8.97M |
| Long-Term Investments | $312.3M | $413.9M | $301.7M | $410.3M | $350.0M | $322.1M | $358.7M | $405.8M |
| Other Non-Current Assets | $909K | -- | -- | $126K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $344.1M | $445.7M | $334.2M | $442.6M | $382.5M | $355.7M | $392.8M | $434.4M |
| **Total Assets** | $1.22B | $1.31B | $1.03B | $1.11B | $1.19B | $1.04B | $1.10B | $1.12B |
| Accounts Payable | $22.04M | $30.51M | $20.74M | $17.58M | $18.43M | $17.27M | $17.63M | $15.42M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $490K | -- | -- | -- |
| **Total Current Liabilities** | $96.41M | $82.68M | $64.83M | $58.81M | $64.51M | $55.34M | $50.85M | $46.07M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $1.68M | -- | -- | -- |
| **Total Non-Current Liabilities** | $27.55M | $28.12M | $28.25M | $27.57M | $28.59M | $26.28M | $25.66M | $18.87M |
| **Total Liabilities** | $124.0M | $110.8M | $93.08M | $86.39M | $93.10M | $81.62M | $76.51M | $64.94M |
| **Total Debt (incl. Leases)** | $29.70M | $29.31M | $28.60M | $27.91M | $27.25M | $26.60M | $25.97M | $19.17M |
| Common Stock | $10K | $10K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K |
| Retained Earnings | -$1.07B | -$947.5M | -$835.1M | -$736.5M | -$653.3M | -$772.5M | -$695.0M | -$622.8M |
| Accumulated Other Comp. Income | -$4.88M | -$1.67M | -$494K | $2.27M | $2.05M | $1.52M | $1.58M | $812K |
| **Total Stockholders' Equity** | $1.09B | $1.20B | $937.3M | $1.02B | $1.09B | $959.7M | $1.02B | $1.06B |
| Total Equity | $1.09B | $1.20B | $937.3M | $1.02B | $1.09B | $959.7M | $1.02B | $1.06B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$113.7M | -$274.5M | -$113.0M | -$58.66M | -$49.76M | -$34.49M | -$41.98M | -$34.35M | -$11.86M |
| Depreciation & Amortization | $2.70M | $2.39M | $2.48M | $2.10M | $1.73M | $1.38M | $1.25M | $886K | $391K |
| Stock-Based Compensation | $46.12M | $34.75M | $18.49M | $11.63M | $8.24M | $3.61M | $2.17M | $950K | $136K |
| Change in Receivables | $0 | $0 | $193K | $892K | $774K | -$1.88M | $0 | -- | -- |
| Change in Payables | $2.70M | $8.28M | $2.63M | $1.86M | $1.17M | $225K | -$195K | $322K | $254K |
| **Operating Cash Flow** | -$71.10M | -$247.6M | -$115.2M | -$87.17M | -$55.78M | $55.46M | -$39.31M | -$27.62M | -$12.22M |
| Capital Expenditure | -$2.37M | -$3.86M | -$2.37M | -$3.44M | -$2.64M | -$493K | -$1.35M | -$1.71M | -$1.76M |
| **Free Cash Flow** | -$73.47M | -$251.4M | -$117.6M | -$90.62M | -$58.42M | $54.97M | -$40.67M | -$29.33M | -$13.98M |
| Purchases of Investments | -$607.9M | -$1.19B | -$596.0M | -$255.8M | -$315.0M | -$242.3M | -$88.00M | -$133.3M | -$13.47M |
| Sales & Maturities of Investments | -- | -- | $439.9M | $225.8M | $248.0M | -- | -- | -- | -- |
| **Investing Cash Flow** | $69.98M | -$502.6M | -$158.5M | -$33.40M | -$69.67M | -$146.2M | $2.27M | -$63.18M | -$8.93M |
| Common Stock Issued | $0 | $274.4M | $281.2M | $86.11M | $85.99M | $100.7M | $50.32M | -- | -- |
| **Financing Cash Flow** | $29.78M | $677.6M | $362.7M | $97.17M | $145.5M | $128.8M | $50.61M | $105.4M | $17.49M |
| **Net Change in Cash** | $28.66M | -$72.59M | $89.04M | -$23.41M | $20.01M | $37.97M | $13.56M | $14.58M | -$3.66M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$125.7M | -$112.5M | -$98.54M | -$83.27M | $119.2M | -$77.49M | -$72.18M | -$130.3M |
| Depreciation & Amortization | $614K | $688K | $688K | $721K | $661K | $718K | $600K | $572K |
| Stock-Based Compensation | $17.73M | $16.66M | $14.54M | $11.79M | $12.22M | $11.87M | $10.24M | $9.48M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $2.0K |
| Change in Payables | -$7.50M | $8.89M | $3.05M | -$858K | $1.19M | -$364K | $2.73M | $2.98M |
| **Operating Cash Flow** | -$93.48M | -$88.21M | -$75.17M | -$90.50M | $142.2M | -$62.47M | -$60.34M | -$121.7M |
| Capital Expenditure | -$273K | -$866K | -$967K | -$333K | -$42K | -$663K | -$1.33M | -$1.10M |
| **Free Cash Flow** | -$93.75M | -$89.08M | -$76.14M | -$90.83M | $142.2M | -$63.14M | -$61.67M | -$122.8M |
| Purchases of Investments | -$63.37M | -$313.4M | -$42.61M | -$236.1M | -$139.0M | -$127.6M | -$105.2M | -$337.0M |
| **Investing Cash Flow** | $78.65M | -$155.9M | $119.0M | -$97.53M | $41.77M | $45.92M | $79.82M | -$197.1M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -$340K |
| **Financing Cash Flow** | $3.69M | $359.2M | $1.18M | $2.13M | $301K | $1.21M | $26.14M | $2.75M |
| **Net Change in Cash** | -$11.14M | $115.1M | $44.96M | -$185.9M | $184.3M | -$15.35M | $45.62M | -$316.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -72.8% | -4671.1% | -574.9% | -122.7% | -179.9% | -180.9% | -- | -- | -- |
| **Net Profit Margin** | -52.0% | -3921.1% | -483.0% | -115.2% | -178.1% | -176.6% | -- | -- | -- |
| Return on Equity (ROE) | -11.1% | -25.9% | -18.2% | -16.8% | -16.5% | -17.4% | -41.8% | -- | -- |
| Return on Assets (ROA) | -10.2% | -24.4% | -17.4% | -15.1% | -13.0% | -11.6% | -37.1% | -35.6% | -- |
| Current Ratio | 11.34x | 14.97x | 19.65x | 11.68x | 5.56x | 7.47x | 14.65x | 16.75x | -- |
| Quick Ratio | 10.87x | 14.68x | 19.38x | 11.51x | 5.49x | 7.39x | 14.26x | 16.62x | -- |
| Debt to Equity | 0.03x | 0.02x | 0.00x | 0.01x | 0.02x | 0.03x | 0.07x | -- | -- |
| **Revenue Growth (YoY)** | +3024.4% | -70.1% | -54.1% | +82.3% | +43.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -200.6% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -206.3% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +212.8% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -4671.1% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -3921.1% |
| Return on Equity (ROE) | -38.5% | -14.6% | -14.9% | -11.1% | -14.7% | -34.6% | -30.0% | -25.9% |
| Return on Assets (ROA) | -34.5% | -13.4% | -13.6% | -10.2% | -13.6% | -31.9% | -27.9% | -24.4% |
| Current Ratio | 9.04x | 10.45x | 10.74x | 11.34x | 12.44x | 12.39x | 13.92x | 14.97x |
| Quick Ratio | 8.70x | 10.03x | 10.35x | 10.87x | 12.20x | 12.10x | 13.62x | 14.68x |
| Debt to Equity | 0.03x | 0.02x | 0.03x | 0.03x | 0.02x | 0.03x | 0.03x | 0.02x |
| **Revenue Growth (YoY)** | -95.1% | -- | -- | -- | -- | -- | -- | +78.5% |
| Operating Income Growth (YoY) | -226.9% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -205.5% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -190.4% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -165.7% | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -165.9% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
